KAITLYN WHITE: Open Payments
NPI 1205306404 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,684 in 93 payments from 16 companies in 2025. Trend: 2023 $1,779 · 2024 $2,587 · 2025 $1,684
Food & beverage: $1,584Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $301 |
| LEO Pharma Inc. | 20 | $215 |
| UCB, Inc. | 9 | $199 |
| PFIZER INC. | 12 | $176 |
| Novartis Pharmaceuticals Corporation | 10 | $176 |
| Arcutis Biotherapeutics, Inc. | 7 | $157 |
| GENZYME CORPORATION | 8 | $138 |
| Regeneron Healthcare Solutions, Inc. | 3 | $96 |
| Galderma Laboratories, L.P. | 2 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
Products named: TREMFYA, DUPIXENT, Bimzelx, CIBINQO, COSENTYX, ADBRY, ANZUPGO, NEMLUVIO.
Industry payments across OK — which companies pay providers there.
